We are live on ! Find out more
EHC icon

Encompass Health

544 hedge funds and large institutions have $8.84B invested in Encompass Health in 2024 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 207 increasing their positions, 162 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

219% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 31

161% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $3.86M

28% more repeat investments, than reductions

Existing positions increased: 207 | Existing positions reduced: 162

13% more funds holding

Funds holding: 482544 (+62)

0.04% less ownership

Funds ownership: 95.02%94.98% (-0.04%)

4% less capital invested

Capital invested by funds: $9.24B → $8.84B (-$403M)

33% less funds holding in top 10

Funds holding in top 10: 96 (-3)

Holders
544
Holders Change
+62
Holders Change %
+12.86%
% of All Funds
7.15%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.08%
New
99
Increased
207
Reduced
162
Closed
31
Calls
$10.1M
Puts
$3.86M
Net Calls
+$6.21M
Net Calls Change
-$4.86M

EHC Hedge Fund Activity: Q4 2024 in Review

544 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Encompass Health (EHC) for Q4 2024, worth a combined $8.84B — down 4.4% from $9.24B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new EHC positions and 31 closed out — a net gain of 68 holders — while 207 added to existing stakes and 162 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $163M. The largest seller was William Blair Investment Management, cutting an estimated $142M.

  • 544 institutional investors held Encompass Health (EHC) as of Q4 2024, up from 482 in Q3 2024.
  • Funds reported $8.84B of Encompass Health stock for Q4 2024, down 4.4% quarter-over-quarter.
  • 99 funds opened new Encompass Health positions in Q4 2024 and 31 closed out, a net change of +68 holders.
  • The largest Encompass Health buyer in Q4 2024 was T. Rowe Price Investment Management, an estimated $163M added.
  • The largest Encompass Health seller in Q4 2024 was William Blair Investment Management, an estimated $142M sold.

Based on aggregated 13F filings for Q4 2024.